{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:40:56Z","timestamp":1789706456553,"version":"4.0.1"},"reference-count":21,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,1,26]]},"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>Octreotide is a somatostatin analogue used for treating congenital chylothorax and congenital hyperinsulinism in infants. By increasing splanchnic arteriolar resistance and decreasing gastrointestinal blood flow, octreotide indirectly reduces lymphatic flow in chylous effusions.<\/jats:p>\n               <jats:p>Splanchnic ischaemia following octreotide predisposes infants to necrotising enterocolitis (NEC). Although NEC occurrence in infants treated with octreotide for hyperinsulinaemic hypoglycaemia has been reported widely, its incidence in infants with chylothroax is low. We describe a case of congenital chylothorax in a preterm infant who had poor response to thoracentesis. Although octreotide initiation lead to resolution of chylothorax, he developed NEC. Cessation of octreotide and medical management resulted in rapid resolution of NEC. Since octreotide is generally used as the first-line treatment for chylous effusion, the risk of NEC should be considered, especially when the dosage is increased. Infants on octreotide should be closely observed for early signs and symptoms of NEC to avert surgical emergency.<\/jats:p>","DOI":"10.1136\/bcr-2019-232062","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T04:15:24Z","timestamp":1581480924000},"page":"e232062","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Necrotising enterocolitis in a newborn infant treated with octreotide for chylous effusion: is octreotide safe?"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-7441","authenticated-orcid":false,"given":"Suresh","family":"Chandran","sequence":"first","affiliation":[{"name":"Department of Neonatology, KK Women's and Children's Hospital, Singapore"},{"name":"Department of Neonatology, Duke NUS Medical School, Singapore"},{"name":"Department of Neonatology, NUS Yong Loo Lin School of Medicine, Singapore"},{"name":"Department of Neonatology, Lee Kong Chian School of Medicine, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Neonatology, KK Women's and Children's Hospital, Singapore"},{"name":"Department of Neonatology, Duke NUS Medical School, Singapore"},{"name":"Department of Neonatology, NUS Yong Loo Lin School of Medicine, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve Villablanca","family":"Llanora","sequence":"additional","affiliation":[{"name":"Department of Neonatology, KK Women's and Children's Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Chien","family":"Chua","sequence":"additional","affiliation":[{"name":"Department of Neonatology, KK Women's and Children's Hospital, Singapore"},{"name":"Department of Neonatology, Duke NUS Medical School, Singapore"},{"name":"Department of Neonatology, NUS Yong Loo Lin School of Medicine, Singapore"},{"name":"Department of Neonatology, Lee Kong Chian School of Medicine, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"2025082702531285000_13.2.e232062.1","doi-asserted-by":"publisher","DOI":"10.4065\/84.2.129"},{"key":"2025082702531285000_13.2.e232062.2","doi-asserted-by":"publisher","DOI":"10.1542\/neo.5-1-e5"},{"key":"2025082702531285000_13.2.e232062.3","article-title":"Octreotide for the treatment of chylothorax in neonates","volume":"49","author":"Das","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2025082702531285000_13.2.e232062.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-006-0114-9"},{"key":"2025082702531285000_13.2.e232062.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2004.00471.x"},{"key":"2025082702531285000_13.2.e232062.6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000443959","article-title":"Late presentation of fulminant necrotizing enterocolitis in a child with hyperinsulinism on octreotide therapy","volume":"86","author":"Hawkes","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"2025082702531285000_13.2.e232062.7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pedneo.2015.07.001","article-title":"Prenatal therapy improves the survival of premature infants with congenital chylothorax","volume":"57","author":"Lee","year":"2016","journal-title":"Pediatr Neonatol"},{"key":"2025082702531285000_13.2.e232062.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601253340408"},{"key":"2025082702531285000_13.2.e232062.9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007594","article-title":"Effects of somatostatin\/octreotide treatment in neonates with congenital chylothorax","volume":"96","author":"Yin","year":"2017","journal-title":"Medicine"},{"key":"2025082702531285000_13.2.e232062.10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000007638","article-title":"Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers","volume":"60","author":"Schiedermaier","year":"1999","journal-title":"Digestion"},{"key":"2025082702531285000_13.2.e232062.11","first-page":"443","article-title":"Circulatory effects of somatostatin in anesthetized man","volume":"145","author":"Tyd\u00e9n","year":"1979","journal-title":"Acta Chir Scand"},{"key":"2025082702531285000_13.2.e232062.12","doi-asserted-by":"publisher","DOI":"10.1097\/01.PCC.0000123552.36127.22"},{"key":"2025082702531285000_13.2.e232062.13","doi-asserted-by":"crossref","DOI":"10.21699\/ajcr.v8i5.628","article-title":"Necrotizing enterocolitis after octreotide treatment in a preterm newborn with idiopathic congenital chylothorax","volume":"8","author":"B\u00fcy\u00fcktiryaki","year":"2017","journal-title":"APSP J Case Rep"},{"key":"2025082702531285000_13.2.e232062.14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s13312-015-0772-1","article-title":"Hyperinsulinemic hypoglycemia in infancy: current concepts in diagnosis and management","volume":"52","author":"Vora","year":"2015","journal-title":"Indian Pediatr"},{"key":"2025082702531285000_13.2.e232062.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2009.00547.x"},{"key":"2025082702531285000_13.2.e232062.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2008.02.062"},{"key":"2025082702531285000_13.2.e232062.17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/pds.4144","article-title":"Octreotide use and safety in infants with hyperinsulinism","volume":"26","author":"McMahon","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025082702531285000_13.2.e232062.18","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2025082702531285000_13.2.e232062.19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/jp.2015.10","article-title":"Congenital chylothorax treated with oral sildenafil: a case report and review of the literature","volume":"35","author":"Malleske","year":"2015","journal-title":"J Perinatol"},{"key":"2025082702531285000_13.2.e232062.20","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23124"},{"key":"2025082702531285000_13.2.e232062.21","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26470","article-title":"Developmental pharmacokinetics of sirolimus: implications for precision dosing in neonates and infants with complicated vascular anomalies","volume":"64","author":"Mizuno","year":"2017","journal-title":"Pediatr Blood Cancer"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-232062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:53:23Z","timestamp":1756288403000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-232062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,11]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/bcr-2019-232062"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-232062","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}